Latest News

Subsense announces “major expansion” of AI-driven strategy to develop non-surgical BCI...

Subsense—an artificial intelligence (AI)-native neurotechnology company developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs)—has announced a major expansion of its AI-driven NanoBCI strategy, bringing together AI,...

Features

WFITN seeks to balance education and innovation during period of “exponential...

With the World Federation of Interventional and Therapeutic Neuroradiology’s (WFITN) 2026 congress (11–15 October, Busan, South Korea) looming large on the horizon, incoming WFITN...

Less waiting, shorter stays, and the same high standards: the future...

A study recently published in Stroke: Vascular and Interventional Neurology has found that diagnostic cerebral angiographies performed in the ambulatory setting can be completed...

Videos

In part two of our special focus on CREST-2, William Gray (Main Line Health, Philadelphia, USA) is once again joined in the CX Studio...

Most read

Features

Profiles

Christian Taschner

Guilherme Dabus

david liebeskind

David Liebeskind